We enrolled 15 individuals with TSC (“TSC” group; mean age 8.2 ± 5.5, 8 males), including 13 with pathogenic variants in TSC2 and 1 with a pathogenic variant in TSC1. This evidence concerns the gene TSC2 and tuberous sclerosis.